Results 191 to 200 of about 7,809 (216)

Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model

Molecular Therapy, 2017
Heather L Gray-Edwards, Amanda R Taylor Dvm, Dacvim, Aime K Johnson   +2 more
exaly  

[GM1 gangliosidosis].

Ceskoslovenska pediatrie, 1981
J, Brachfeldová, K, Brachfeld, M, Elleder, M, Macek, O, Snobl, J, Vavrinec   +5 more
openaire   +1 more source

Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation

Stem Cell Reports, 2020
Haruki Odaka, Hirokazu Furuya, Takumi Era   +2 more
exaly  

GM3-Gangliosidosis

2008
openaire   +1 more source

An inversion of 25 base pairs causes feline G M2 gangliosidosis variant 0

Experimental Neurology, 2004
Douglas R Martin
exaly  

[Gangliosidosis].

Nihon rinsho. Japanese journal of clinical medicine, 1978
openaire   +1 more source

Gm1 Gangliosidosis Type I

American Journal of Ophthalmology, 1973
M J, Weiss, A E, Krill, G, Dawson, J, Hindman, E, Cotlier   +4 more
openaire   +2 more sources

Juvenile GM 2 Gangliosidosis Variant B 1: Clinical and Biochemical Study in Seven Patients

Neuropediatrics, 1990
Mauricio Maia
exaly  

GM1 Gangliosidosis

2014
openaire   +1 more source

Biochemical Basis of Type AB GM2Gangliosidosis in a Japanese Spaniel

Journal of Neurochemistry, 1987
Yu-Teh Li
exaly